Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mach7 Technologies ( (AU:M7T) ) has provided an announcement.
Mach7 Technologies has announced the resignation of Chief Financial Officer Daniel Lee, who is leaving the role to focus on family priorities, and will stay on for a period to ensure an orderly transition. The Board has thanked Lee for his contributions as he assists with the handover to his successor.
The company has appointed Vice President of Commercial Excellence Shawni Hadfield as Interim CFO with immediate effect, leveraging her prior CFO experience and deep SaaS financial management expertise. Mach7 expects her appointment to strengthen links between sales, support and finance teams, underpin continuity and reinforce disciplined execution across its financial and operational functions.
The most recent analyst rating on (AU:M7T) stock is a Buy with a A$0.44 price target. To see the full list of analyst forecasts on Mach7 Technologies stock, see the AU:M7T Stock Forecast page.
More about Mach7 Technologies
Mach7 Technologies is an ASX-listed healthcare software provider specialising in enterprise imaging platforms that allow healthcare organisations to securely store, manage, access and share diagnostic imaging data across complex environments. Its platform integrates a Vendor Neutral Archive, the eUnity Enterprise Diagnostic Viewer and the Flamingo modules to enhance workflow, interoperability and data management, supporting AI-driven clinical use cases and major cloud ecosystems such as Amazon Web Services for customers including integrated delivery networks, national health systems and specialist imaging providers worldwide.
YTD Price Performance: -56.91%
Average Trading Volume: 158,704
Technical Sentiment Signal: Sell
Current Market Cap: A$62.28M
For an in-depth examination of M7T stock, go to TipRanks’ Overview page.